2.https://www.who.int/zh/news/item/05-03-2024-new-report-documents-increase-in-hiv-drug-resistance-to-dolutegravir
1、https://weibo.com/u/7434146506 2、世卫组织网站主页新闻稿新报告记录显示,艾滋病毒对多替拉韦的耐药性出现上升https://www.who.int/zh/news/item/05-03-2024-new-report-documents-increase-in-hiv-drug-resistance-to-dolutegravir
[4] WHO. HIV drug resistance – brief report 2024. Accessed February 2024. Available at: https://www.who.int/publications/i/item/9789240086319. [5] WHO. New report on HIV drug resistance: Challenges and recommendations. Accessed: April 2024. Available at: https://www.news-medical.net/news...
[3]Jeffrey JL, St Clair M, Wang P, Wang C, Li Z, Beloor J, et al. Impact of integrase sequences from HIV-1 subtypes A6/A1 on the in vitro potency of cabotegravir or rilpivirine. Antimicrob Agents Chemother....
[4] WHO. HIV drug resistance report 2021. Accessed: November 2021. Available at: https://www.who.int/publications/i/item/9789240038608. [5] 赵燕, 甘秀敏, 赵德才, 等. 我国艾滋病抗病毒治疗进展及推进高质量发展的思考[J]. 中国艾滋病性病, 2023, 06: 619-622. ...
[4] WHO. HIV drug resistance report 2021. Accessed: November 2021. Available at: https://www.who.int/publications/i/item/9789240038608. [5] 赵燕, 甘秀敏, 赵德才, 等. 我国艾滋病抗病毒治疗进展及推进高质量发展的思考[J]. 中国艾滋病性病, 2023, 06: 619-622. ...
[4] WHO. HIV drug resistance report 2021. Accessed: November 2021. Available at: https://www.who.int/publications/i/item/9789240038608. [5] 赵燕, 甘秀敏, 赵德才, 等. 我国艾滋病抗病毒治疗进展及推进高质量发展的思考[J]. 中国艾滋病性病, 2023, 06: 619-622. ...
HIV drug resistance testing. (Report from Europe).Clark, Tom
[13]Lee CY, et al. Infect Dis Ther 2022. [14]Chen LY, et al. APACC 2021, Poster 22 [15]Chen LY, et al. J Microbiol Immunol Infect. 2023. [16]HIV drug resistance report 2021. [17]Zhang T, Ding H, An M, et al. Factors associated with high-risk low-level viremia leading to...
1:HIV variants Resistance to Drugs (source: Scientific American,1998) 2:who HIV drug resistance report 2012 3:Linda F Discotto,Michael J Pucci,Laura E Lawrence & John F Barrett (1998) 38th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC),September 24-27,1998,San Diego,...